메뉴 건너뛰기




Volumn 22, Issue 10, 2009, Pages 68-77

Biopharmaceuticals: Approval Trends in 2008

Author keywords

[No Author keywords available]

Indexed keywords

ACCRETROPIN; CERTOLIZUMAB PEGOL; EXTAVIA; HUMAN GROWTH HORMONE; INSULIN ASPART; NOVOLOG MIX; PEGINTRON RIBETOL; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GROWTH HORMONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT PROTEIN; RECOTHROM; RILONACEPT; ROMIPLOSTIM; THROMBIN; UNCLASSIFIED DRUG;

EID: 77951632179     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey
Times cited : (4)

References (6)
  • 1
    • 20644431995 scopus 로고    scopus 로고
    • Biopharmaceuticals: Approvals and approval trends in 2004
    • Walsh G. Biopharmaceuticals: approvals and approval trends in 2004. Biopharm Int. 2005;18,58-65. (Pubitemid 40835187)
    • (2005) BioPharm International , vol.18 , Issue.5 , pp. 58-65
    • Walsh, G.1
  • 2
    • 33747164744 scopus 로고    scopus 로고
    • Biopharmaceuticals: Approval trends in 2005
    • Walsh G. Biopharmaceuticals: approval trends in 2005. BioPharm Int. 2006;9:58-68. (Pubitemid 44232258)
    • (2006) BioPharm International , vol.19 , Issue.8 , pp. 58-68
    • Walsh, G.1
  • 3
    • 35348843937 scopus 로고    scopus 로고
    • Biopharmaceuticals: Approval trends in 2006
    • Walsh G. Biopharmaceuticals: approval trends in 2006. BioPharm Int. 2007:20:40-48. (Pubitemid 47573235)
    • (2007) BioPharm International , vol.20 , Issue.9 , pp. 56-67
    • Walsh, G.1
  • 4
    • 56249114151 scopus 로고    scopus 로고
    • Biopharmaceuticals: Approval trends in 2007
    • Walsh G. Biopharmaceuticals: approval trends in 2007. BioPharm Int. 2008:21:52-65.
    • (2008) BioPharm Int. , vol.21 , pp. 52-65
    • Walsh, G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.